Efficacy and Safety of Nasonex Vs. Placebo in Subjects With SAR and Concomitant Asthma (Study P03280)(COMPLETED) - Contacts and Locations

Home

Efficacy and Safety of Nasonex Vs. Placebo in Subjects With SAR and Concomitant Asthma (Study P03280)(COMPLETED)

This study has been completed.

Study NCT00070707. Last updated on May 31, 2006. Information provided by Schering-Plough

Please refer to this study by its ClinicalTrials.gov identifier: NCT00070707

Sponsors and Collaborators

Schering-Plough

Integrated Therapeutics Group